Determination of subepithelial deposits of IgA antibodies to tissue transglutaminase: practical experience with application for diagnosis of gluten-sensitive celiac disease


Cite item

Full Text

Abstract

Aim. To estimate subepithelial deposites of IgA antibodies to tissue transglutaminase (IGA-tTG) in biopsy specimens of small intestinal mucosa and to determine its diagnostic significance for detection of gluten-sensitive celiac disease (GSCD).
Material and methods. Enzyme immunoassay examined IGA-tTG deposits after their isolation from biopsy specimens of small intestinal mucosa of 53 patients with GSCD and 45 control patients.
Results. Elevated levels of IGA-tTG deposits were found in 98% patients with GSCD. This elevation in the controls occurred in patients with autoimmune pathology and in patients with such levels of the serum markers which were in the range of reference limits in the absence of GSCD morphometric characteristics in biopsy specimen but with verified diagnosis celiac disease.
Conclusion. This method showed high diagnostic efficacy in detection of subepithelial IGA-tTG deposits for diagnosis of GSCD and monitoring of pathogenetic diet therapy.

About the authors

Natal'ya Vasil'evna Vokhmyanina

Email: spbnat@yandex.ru

A V Kozlov

Asfol'd Ivanovich Parfenov

Email: asfold@mail.ru

Lyudmila Savarbekovna Oreshko

Email: oreshko@yandex.ru

N V Vokhmyanina

Medicogenetic Diagnostic Center, Moscow

Medicogenetic Diagnostic Center, Moscow

A V Kozlov

Medical Academy of Postgraduate Education, St-Peterburg

Medical Academy of Postgraduate Education, St-Peterburg

A I Parfenov

Central Research Institute of Gastroenterology, Moscow

Central Research Institute of Gastroenterology, Moscow

L S Oreshko

I.I. Mechnikov St-Petersburg State Medical Academy

I.I. Mechnikov St-Petersburg State Medical Academy

References

  1. Auricchio R., Troncone R. Diagnosis of celiac disease. Pediatr. Adolesc. Med. 2008; 12: 107-113.
  2. Fleckenstein B. et al. Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J. Biol. Chem. 2004; 279 (17): 17607-17616.
  3. Korponay-Szabo I. R. et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by celiac autoantibodies. Gut 2004; 53: 641-648.
  4. Marsh M. N. Gluten, major histocompatibility complex, and the small intestine:a molecular and immunobiologic approach to the spectrum of gluten sensitivity ("celiac sprue"). Gastroenterology 1992; 102: 330-354.
  5. Kagnoff M. F. Celiac disease: pathogenesis of a model immunogenetic disease. J. Clin. Invest. 2007; 117 (1): 41-49.
  6. Вохмянина Н. В. Опыт НLА-типирования больных целиакией. Мед. генетика 2010; 7: 33-41.
  7. Вохмянина Н. В. Тканевая трансглутаминаза (ТG2) и антитела к тканевой трансглутаминазе при воспалительных заболеваниях кишечника. Вестн. Санкт-Петербург. гос. мед. акад. им. И. И. Мечникова. 2009; 1: 9-13.
  8. Lahdeaho M. L. et al. Celiac disease - from inflammatory to atrophy: a long term follow up study. J. Pediatr. Gastroenterol. Nutr. 2005; 41: 44-48.
  9. Weir D. C. et al. Variability of histopathological changes in childhood celiac disease. Am. J. Gastroenterol. 2010; 105: 207-212.
  10. Matysiak-Budnik T. et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferring receptor in celiac disease. J. Exp. Med. 2008; 205 (1): 143-154.
  11. Sblattero D. et al. The gut as site of production of autoimmune antibodies. J. Pediatr. Gastroenterol. Nutr. 2004; 39: 730-734.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2012 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

© 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies